| Followers | 19 |
| Posts | 6562 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Friday, May 19, 2023 3:20:30 AM
WISE WQLF SAYS;
THE REASON FOR THE NEW LOGO. THE company could not get the old logo registered with the USPTO. Good Eye HEMP. Have Mercy Have Partnerships Have Faith WISE WQLF Ahooooooo
Status: Suspension check completed. Application remains suspended.
Status Date: Nov. 21, 2022
The following refusal(s) and/or requirement(s) is/are maintained and continued:
Section 2(d) Refusal – Likelihood of Confusion
Disclaimer Requirement
https://tsdr.uspto.gov/#caseNumber=90011385&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Dr. Joong J Fang Said; Check out this SNAFU
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171944789
THE REASON FOR THE NEW LOGO. THE company could not get the old logo registered with the USPTO. Good Eye HEMP. Have Mercy Have Partnerships Have Faith WISE WQLF Ahooooooo
Status: Suspension check completed. Application remains suspended.
Status Date: Nov. 21, 2022
The following refusal(s) and/or requirement(s) is/are maintained and continued:
Section 2(d) Refusal – Likelihood of Confusion
Disclaimer Requirement
https://tsdr.uspto.gov/#caseNumber=90011385&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Dr. Joong J Fang Said; Check out this SNAFU
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171944789
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
